Caricamento...
Identification of in vitro and in vivo disconnects using transcriptomic data
BACKGROUND: Integrating transcriptomic experiments within drug development is increasingly advocated for the early detection of toxicity. This is partly to reduce costs related to drug failures in the late, and expensive phases of clinical trials. Such an approach has proven useful both in the study...
Salvato in:
| Pubblicato in: | BMC Genomics |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539666/ https://ncbi.nlm.nih.gov/pubmed/26282683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12864-015-1726-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|